Information on biocides
Information on biocides
Information on biocides
Osnovno načelo v uredbi o biocidnih proizvodih (Uredba (EU) št. 528/2012 – BPR) je, da mora biti biocidni proizvod odobren, preden se lahko prodaja na trgu ali uporablja v Evropskem gospodarskem prostoru (EGP) in Švici. To poteka v dveh zaporednih korakih. Prvič, aktivna snov se oceni in se nato odobri za uporabo v določeni vrsti proizvoda, če so izpolnjena vsa zahtevana merila. Drugi korak je odobritev vsakega posameznega proizvoda, ki je bodisi sestavljen iz te odobrene aktivne snovi, jo vsebuje ali ustvarja. Na tej strani je opisan zgolj prvi korak.
Podatki na tej strani so urejeni po posameznih aktivnih snoveh/vrstah proizvodov. To se odraža v vseh iskalnih filtrih in rezultatih iskanj. V spodnji preglednici so prikazane informacije za vsako kombinacijo aktivne snovi/vrste proizvoda. Za optimizacijo iskanja se izraz aktivna snov uporablja kot sopomenka za kombinacijo aktivnih snovi/vrst proizvodov.
Podatkovna zbirka vključuje vse aktivne snovi, vključene v program sistematičnega preverjanja vseh obstoječih aktivnih snovi, tiste, ki vanj niso vključene, kot tudi snovi iz Priloge I k uredbi o biocidnih proizvodih. Več informacij o kategorizaciji aktivnih snovi je na voljo na spletni strani Izdaja dovoljenj za aktivne snovi.
Več informacij o postopku iskanja in načinu predstavitve informacij je na voljo v nadaljevanju.
Kako iskati?
Informacije o biocidnih aktivnih snoveh si lahko ogledate na dva načina:
– za vsako posamezno kombinacijo aktivnih snovi in vrst proizvodov (uporabite zavihek „Išči“) in
– v obliki povzetka vseh vlog za izdajo dovoljenja za določeno vrsto proizvoda, ki so bile vložene za dano aktivno snov (zavihek „Povzetek“).
Pod zavihkom „Išči“ lahko iščete po:
– podatkih o posamezni aktivni snovi: identifikatorji snovi, vrsta proizvoda, kandidatka za zamenjavo.
(Privzet status v polju „Kandidatka za zamenjavo“ je "v postopku ocenjevanja", vendar to ne pomeni nujno, da je aktivna snov potencialna kandidatka za zamenjavo. Ko je aktivna snov enkrat opredeljena ali ne kot potencialna kandidatka za zamenjavo, se status ustrezno spremeni v „da“ ali „ne“);
– podatkih o postopku izdaje dovoljenja: na primer status vloge za izdajo dovoljenja, faza ocenjevanja v postopku, veljavnost izdanega dovoljenja;
– sorodnih odobrenih biocidnih proizvodih (trgovsko ime biocidnega proizvoda).
Način predstavitve informacij
V preglednici zadetkov iskanja so predstavljene informacije o aktivni snovi, kot sta datum začetka in datum poteka veljavnosti dovoljenja, pristojni organ, ki je izvedel ocenjevanje, ter status postopka za izdajo dovoljenja ali postopka ocenjevanja. Ime snovi je hiperpovezava na stran z informacijami o tej snovi (infokartica), ki povzema podatke o snovi iz vseh regulativnih okvirov, ki jih upravlja agencija ECHA.
Podatki o aktivnih snoveh se črpajo iz registra biocidnih proizvodov (R4BP 3). Ta zajema informacije o aktivnih snoveh, za katere je bila vložena vloga za odobritev uporabe v določenih vrstah biocidnih proizvodov v skladu z uredbo o biocidnih proizvodih ali direktivo o biocidnih proizvodih (Direktiva 98/8/ES). Da se lahko podatki o aktivni snovi razširjajo ali za prikaz posodobljenega statusa v postopku odobritve, mora snov uspešno prestati korak potrditve v registru R4BP 3.
Več informacij o odobritvi posamezne aktivne snovi je na voljo v informativnem listu (dostopnem prek ikone očesa v preglednici z zadetki iskanja). Informativni list vsebuje najnovejše podrobnosti o postopku odobritve, vključno z ustreznimi dokumenti in povezanimi odobrenimi biocidnimi proizvodi, ter pregled vseh sprememb dovoljenja za zadevno aktivno snov.
V preglednici z zadetki iskanja je vidno tudi število povezanih odobrenih biocidnih proizvodov. To število predstavlja seštevek vseh sklopov proizvodov (skupin dovoljenj), ki vsebujejo zadevno aktivno snov.
V zavihku „Povzetek“ so navedene vse vloge za vrsto proizvodov, ki so bile predložene za določeno aktivno snov, ne glede na to, ali je bila vloga odobrena ali zavrnjena. Status odobritve aktivne snovi in kombinacija vrst proizvodov sta označena z ikono. Če se z miško pomaknete čez njo, lahko vidite status vloge za izdajo dovoljenja in fazo v postopku ocenjevanja, če je postopek izdaje dovoljenja še v teku, ter s klikom nanjo dostopate do informativnega lista o aktivni snovi.
Izvoz zadetkov iskanja
Zadetke iskanja aktivnih snovi lahko izvozite v standardnih formatih spletišča agencije ECHA (XLS, CSV in XML).
Due to a technical problem, which is being fixed, certain substance/product-type combinations are currently displayed with an inaccurate status.
Further information
- List of approved active substances
- Approval of active substances
- Understanding the BPR Regulation
- Q&A on Biocidal Products Regulation
- Give us your feedback
- BPC opinions on approval of active substances
- Public consultation on potential candidates for substitution
- Lists of Member States where wood treated with creosote may be placed on the market for certain uses [EN][PDF]
Summary of status of applications for approval of active substance/product-type and Annex I records under the BPD or the BPR.
Annex I | Product-type | ||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Disinfectants | Preservatives | Pest Control | Other | ||||||||||||||||||||||
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | ||||
Annex I substance (+)-Tartaric acid | 201-766-0 | 87-69-4 | Approved | ||||||||||||||||||||||
(1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl (1R-trans)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclo-propanecarboxylate (d-Tetramethrin) | 214-619-0 | 1166-46-7 | Initial application for approval in progress | ||||||||||||||||||||||
(13Z)-Hexadec-13-en-11-yn-1-yl acetate | 642-968-2 | 78617-58-0 | Approved | ||||||||||||||||||||||
(2R,6aS,12aS)-1,2,6,6a,12,12a-hexa- hydro-2-isopropenyl-8,9-dimethoxychro- meno[3,4-b]furo[2,3-h]chromen-6-one (Rotenone) | 201-501-9 | 83-79-4 | Cancelled application | ||||||||||||||||||||||
(9Z,12E)-Tetradeca-9, 12-dien-1-yl acetate | 608-490-3 | 30507-70-1 | No longer supported | ||||||||||||||||||||||
Annex I substance (9Z,12E)-tetradeca-9,12-dien-1-yl acetate | 608-490-3 | 30507-70-1 | Approved | ||||||||||||||||||||||
(benzothiazol-2-ylthio)methyl thiocyanate (TCMTB) | 244-445-0 | 21564-17-0 | Initial application for approval in progress | Initial application for approval in progress | |||||||||||||||||||||
(benzyloxy)methanol | 238-588-8 | 14548-60-8 | Initial application for approval in progress | No longer supported | |||||||||||||||||||||
(E)-1-(2-Chloro-1,3-thiazol-5-ylmethyl)-3- methyl-2-nitroguanidine (Clothianidin) | 433-460-1 | 210880-92-5 | Expired | Approved | |||||||||||||||||||||
(ethylenedioxy)dimethanol (Reaction products of ethylene glycol with paraformaldehyde (EGForm)) | 222-720-6 | 3586-55-8 | No longer supported | Initial application for approval in progress | Initial application for approval in progress | Initial application for approval in progress | Initial application for approval in progress | ||||||||||||||||||
(RS)-3-Allyl-2-methyl-4-oxocyclopent-2- enyl (1R,3R)-2,2-dimethyl-3-(2-methyl- prop-1-enyl)-cyclopropanecarboxylate (mixture of 2 isomers 1R trans: 1R/S only 1:3) (Esbiothrin) | 807-421-6 | 260359-57-7 | Not approved | ||||||||||||||||||||||
(RS)-3-Allyl-2-methyl-4-oxocyclopent-2- enyl-(1R,3R; 1R,3S)-2,2-dimethyl-3-(2- methylprop-1-enyl)-cyclopropanecarboxy- late (mixture of 4 isomers 1R trans, 1R:1R trans, 1S: 1R cis, 1R: 1R cis,1S 4:4:1:1) (d-Allethrin) |
687-634-7 | 231937-89-6 | Not approved | ||||||||||||||||||||||
(RS)-α-cyano-3phenoxybenzyl-(1RS)-cis, trans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate (Cypermethrin) | 257-842-9 | 52315-07-8 | Approved | Approved | |||||||||||||||||||||
1,2-benzisothiazol-3(2H)-one (BIT) | 220-120-9 | 2634-33-5 | Initial application for approval in progress | Initial application for approval in progress | Initial application for approval in progress | No longer supported | Initial application for approval in progress | Initial application for approval in progress | Initial application for approval in progress | ||||||||||||||||
1,3-bis(hydroxymethyl)-5,5-dimethylimidazolidine-2,4-dione (DMDMH) | 229-222-8 | 6440-58-0 | Initial application for approval in progress | Initial application for approval in progress | |||||||||||||||||||||
1-(3,5-dichloro-4-(1,1,2,2-tetrafluoroethoxy)phenyl)-3-(2,6-difluorobenzoyl) urea (Hexaflumuron) | 401-400-1 | 86479-06-3 | Approved | ||||||||||||||||||||||
1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole (Imazalil) | 252-615-0 | 35554-44-0 | No longer supported | ||||||||||||||||||||||
1-[[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl]-1H-1,2,4-triazole (Propiconazole) | 262-104-4 | 60207-90-1 | Approved | Approved | Approved | ||||||||||||||||||||
1-ethynyl-2-methylpent-2-enyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate (Empenthrin) | 259-154-4 | 54406-48-3 | Not approved | ||||||||||||||||||||||
1R-trans phenothrin | 247-431-2 | 26046-85-5 | Approved | ||||||||||||||||||||||
2,2-dibromo-2-cyanoacetamide (DBNPA) | 233-539-7 | 10222-01-2 | No longer supported | Not approved | Initial application for approval in progress | Initial application for approval in progress | Initial application for approval in progress | No longer supported | |||||||||||||||||
2,2′,2′′-(hexahydro-1,3,5-triazine-1,3,5- triyl)triethanol (HHT) | 225-208-0 | 4719-04-4 | Initial application for approval in progress | Initial application for approval in progress | Initial application for approval in progress | Initial application for approval in progress | |||||||||||||||||||
2,2′-dithiobis[N-methylbenzamide] (DTBMA) | 219-768-5 | 2527-58-4 | Initial application for approval in progress | ||||||||||||||||||||||
2-(2-butoxyethoxy)ethyl 6-propylpiper-onyl ether (Piperonyl butoxide/PBO) | 200-076-7 | 51-03-6 | Approved | ||||||||||||||||||||||
2-bromo-2-(bromomethyl)pentanedinitrile (DBDCB) | 252-681-0 | 35691-65-7 | Approved | ||||||||||||||||||||||
2-Butanone, peroxide | 215-661-2 | 1338-23-4 | Not approved | Not approved | Not approved | Not approved | |||||||||||||||||||
2-butyl-benzo[d]isothiazol-3-one (BBIT)
SUBSTANCE S123386;
VANQUISH 100 |
420-590-7 | 4299-07-4 | Initial application for approval in progress | Initial application for approval in progress | Initial application for approval in progress | Initial application for approval in progress | Initial application for approval in progress | ||||||||||||||||||
2-chloro-N-[[[4-(trif luoromethoxy) phenyl]amino]carbonyl]benzamide (Triflumuron) | 264-980-3 | 64628-44-0 | Not approved | ||||||||||||||||||||||
2-hydroxy-α,α,4-trimethylcyclohexanemethanol | 255-953-7 | 42822-86-6 | No longer supported | ||||||||||||||||||||||
2-methyl-2,3-dihydro-1,2-thiazol-3-one hydrochloride | 247-499-3 | 26172-54-3 | Initial application for approval in progress | ||||||||||||||||||||||
2-methyl-2H-isothiazol-3-one (MIT) | 220-239-6 | 2682-20-4 | Initial application for approval in progress | Approved | Approved | Approved | |||||||||||||||||||
2-methyl-4-oxo-3-(prop-2-ynyl)cyclopent-2-en-1-yl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate (Prallethrin) | 245-387-9 | 23031-36-9 | Initial application for approval in progress | ||||||||||||||||||||||
2-octyl-2H-isothiazol-3-one (OIT) | 247-761-7 | 26530-20-1 | Initial application for approval in progress | Initial application for approval in progress | Approved | Initial application for approval in progress | Initial application for approval in progress | Initial application for approval in progress | Initial application for approval in progress | ||||||||||||||||
2-Phenoxyethanol | 204-589-7 | 122-99-6 | Initial application for approval in progress | Initial application for approval in progress | Not approved | Initial application for approval in progress | Initial application for approval in progress | Initial application for approval in progress | |||||||||||||||||
2-Propenoic acid, 2-methyl-, butyl ester, polymer with butyl 2-propenoate and methyl 2-methyl-2-propenoate (CAS nr: 25322-99-0)/ Polymeric quaternary ammonium bromide (PQ Polymer) | - | - | Not approved | Not approved | |||||||||||||||||||||
2-thiazol-4-yl-1H-benzoimidazole (Thiabendazole) | 205-725-8 | 148-79-8 | Initial application for approval in progress | Expired | Initial application for approval in progress | Initial application for approval in progress | |||||||||||||||||||
3-(4-isopropylphenyl)-1,1-dimethylurea/ Isoproturon | 251-835-4 | 34123-59-6 | Initial application for approval in progress | Initial application for approval in progress | |||||||||||||||||||||
3-iodo-2-propynylbutylcarbamate (IPBC) | 259-627-5 | 55406-53-6 | Approved | Initial application for approval in progress | Approved | Initial application for approval in progress | Initial application for approval in progress | Approved | |||||||||||||||||
3-phenoxybenzyl (1R)-cis,trans-2,2- dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate (d-Phenothrin) | - | 188023-86-1 | No longer supported | ||||||||||||||||||||||
4,4-dimethyloxazolidine | 257-048-2 | 51200-87-4 | Not approved | Not approved | Not approved | ||||||||||||||||||||
4,5-Dichloro-2-octylisothiazol-3(2H)-one (4,5-Dichloro-2-octyl-2H-isothiazol-3-one (DCOIT)) | 264-843-8 | 64359-81-5 | Initial application for approval in progress | Approved | Initial application for approval in progress | Initial application for approval in progress | Initial application for approval in progress | Approved | |||||||||||||||||
4-bromo-2-(4-chlorophenyl)-1-ethoxy- methyl-5-trifluoromethylpyrrole-3-carbonitrile (Chlorfenapyr) | 602-782-4 | 122453-73-0 | Approved | Initial application for approval in progress | |||||||||||||||||||||
5-chloro-2-(4-chlorphenoxy)phenol (DCPP) | 429-290-0 | 3380-30-1 | Approved | Approved | Approved | ||||||||||||||||||||
5-Chloro-2-methyl-2H-isothiazol-3-one (CIT) | 247-500-7 | 26172-55-4 | Initial application for approval in progress | ||||||||||||||||||||||
6-(phthalimido)peroxyhexanoic acid (PAP)
PAP
|
410-850-8 | 128275-31-0 | Initial application for approval in progress | Initial application for approval in progress | No longer supported | No longer supported | |||||||||||||||||||
7a-ethyldihydro-1H,3H,5H-oxazolo[3,4-c]oxazole (EDHO) | 231-810-4 | 7747-35-5 | No longer supported | No longer supported | |||||||||||||||||||||
[1.alpha.(S*),3.alpha.]-(.alpha.)-cyano-(3-phenoxyphenyl)methyl3-(2,2-dichlor-oethenyl)-2,2-dichlorovinyl)-2,2-dimethyl-cyclopropanecarboxylate (alpha-Cypermethrin); [1α(S*),3α]-(α)-cyano-(3-phenoxyphenyl)methyl3-(2,2-dichlor-oethenyl)-2,2-dichlorovinyl)-2,2-dimethyl-cyclopropanecarboxylate αCypermethrin) |
614-054-3 | 67375-30-8 | Approved | ||||||||||||||||||||||
[2,4-Dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-cis-chrysanthemate; [2,4- Dioxo-(2-propyn-1-yl)imidazolidin-3-yl] methyl(1R)-trans-chrysanthemate (Imiprothrin) |
428-790-6 | 72963-72-5 | Approved | ||||||||||||||||||||||
Abamectin | 615-339-5 | 71751-41-2 | Expired | ||||||||||||||||||||||
Acetamiprid | 603-921-1 | 135410-20-7 | Approved | ||||||||||||||||||||||
Legend
-
Initial approval in progressApproved - Renewal in progressApproved - Other update in progress
-
Approved
-
Not approved
-
Expired
-
Cancelled application
-
No longer supported